N/A
Completed N=15
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Source: ClinicalTrials.gov NCT04625413 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcomePrimary: Feasibility (Recruitment Rates) — 11 Participants
Summary
This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility (Recruitment Rates) |
11 | — |
| PRIMARY Usefulness |
3.8 | — |
| SECONDARY Pre-post Changes in the Following Outcomes:Perceived Efficacy in Patient-Physician Interactions (PEPPI) |
1.5 | — |
| SECONDARY Pre-post Changes in the Following Outcomes: General Anxiety Disorder-7 |
-1.6 | — |
| SECONDARY Pre-post Changes in the Following Outcomes: Geriatric Depression Scale-15 |
0.2 | — |
Eligibility Criteria
Inclusion Criteria for Patients:
- Age ≥60 years (conventional definition of older age in AML)
- Newly diagnosed AML
- Considering treatment
- Able to provide informed consent
- English-speaking
Inclusion Criteria for Caregivers:
- Selected by the patient when asked if there is a "family member, partner, friend or caregiver [age 21 or older] with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient.
- Able to provide informed consent
- English-speaking
Inclusion Criteria for Oncologists:
- A practicing oncologist
- At least one of their patients are recruited to the study
- English-speaking
Exclusion Criteria: None
Data sourced from ClinicalTrials.gov (NCT04625413). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.